RNA-seq Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Jul 7, 2022 Breast, Ovarian Cancer Study Finds Ties Between Types of BRCA Alterations, Treatment Response Jun 24, 2022 Molecular Tumor Profiling Benefits Pediatric Cancer Patients, Study Finds Jun 23, 2022 MD Anderson Study Explains Differing BRAF/MEK Treatment Responses in Male, Female Melanoma Patients Premium Jun 15, 2022 Estimated Total Tumor mRNA Predicts Cancer Outcomes, Study Shows Premium May 26, 2022 Mass General Hospital Gets Funding to Sequence Rare Melanoma Subtypes, Hunt for Novel Drug Targets Premium Apr 12, 2022 New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia Premium Apr 7, 2022 Pangea Biomed Builds on RNA-Based Drug Matching to Expand Precision Oncology Opportunities Premium Jan 27, 2022 Certain Childhood ALL Subtypes Linked to Genetic Ancestry Dec 23, 2021 Multiomic Profiling Uncovers Predictors of Melanoma Response to Immunotherapy Dec 15, 2021 Researchers Report on Novel Pediatric AML Subtype Associated With Poor Outcomes at ASH Meeting Dec 10, 2021 Researchers ID Genomic Signature to Risk Stratify Patients With Precancerous Breast Lesions Nov 17, 2021 Multiple Myeloma Patient Similarity Network Reveals Prognostically Informative Subgroups Nov 17, 2021 WUSTL Program Aims to Improve Sequencing Rates, Clinical Trial Participation Among Black Cancer Patients Premium Nov 16, 2021 Cancer Genomic Analysis Reveals Distinct Features in Tumors From Patients Under 50 Years Old Nov 11, 2021 Breast Cancer Study Shows Number of Mutated PIK3CA Alleles Affects Tumor Aggressiveness Oct 8, 2021 TGen Study Highlights Value of Repeat Tumor Profiling for Pediatric Solid Tumors Premium Oct 1, 2021 UK Researchers Show Cytotoxic T-Cell Level Predicts Melanoma Immunotherapy Response Sep 21, 2021 ESMO Study Identifies Potential Predictive Biomarkers to ID TNBC Patients for Therapy De-Escalation Sep 16, 2021 Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
